Literature DB >> 16434386

The role of second autografts in the management of myeloma at first relapse.

Caroline L Alvares, Faith E Davies, Clive Horton, Gita Patel, Ray Powles, Gareth J Morgan.   

Abstract

We report an analysis of the value of a second high-dose melphalan autograft, performed at relapse, on a series of newly diagnosed myeloma patients entered into the high-dose program at our center. We conclude that relapse-free survival after the first autograft is a major prognostic factor in determining outcome.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16434386

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  17 in total

Review 1.  Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantation.

Authors:  Nina Shah; Sagar Lonial
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

2.  Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents.

Authors:  D Tremblay; G Lancman; E Moshier; N Bar; S Jagannath; A Chari
Journal:  Bone Marrow Transplant       Date:  2017-07-24       Impact factor: 5.483

Review 3.  Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers.

Authors:  Mohamad Mohty; Jean-Luc Harousseau
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

Review 4.  The Diagnosis and Treatment of Multiple Myeloma.

Authors:  Christian Gerecke; Stephan Fuhrmann; Susanne Strifler; Martin Schmidt-Hieber; Hermann Einsele; Stefan Knop
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

Review 5.  The evolution of stem-cell transplantation in multiple myeloma.

Authors:  Sarakshi Mahajan; Nidhi Tandon; Shaji Kumar
Journal:  Ther Adv Hematol       Date:  2018-03-05

Review 6.  Role of autologous stem cell transplantation in multiple myeloma.

Authors:  Shaji Kumar
Journal:  Curr Hematol Malig Rep       Date:  2007-05       Impact factor: 3.952

Review 7.  Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Authors:  J Laubach; L Garderet; A Mahindra; G Gahrton; J Caers; O Sezer; P Voorhees; X Leleu; H E Johnsen; M Streetly; A Jurczyszyn; H Ludwig; U-H Mellqvist; W-J Chng; L Pilarski; H Einsele; J Hou; I Turesson; E Zamagni; C S Chim; A Mazumder; J Westin; J Lu; T Reiman; S Kristinsson; D Joshua; M Roussel; P O'Gorman; E Terpos; P McCarthy; M Dimopoulos; P Moreau; R Z Orlowski; J S Miguel; K C Anderson; A Palumbo; S Kumar; V Rajkumar; B Durie; P G Richardson
Journal:  Leukemia       Date:  2015-12-29       Impact factor: 11.528

8.  American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Authors:  Sergio Giralt; Laurent Garderet; Brian Durie; Gordon Cook; Gosta Gahrton; Benedetto Bruno; Paremesweran Hari; Henk Lokhorst; Phillip McCarthy; Amrita Krishnan; Pieter Sonneveld; Harmut Goldschmidt; Sundar Jagannath; Bart Barlogie; Maria Mateos; Peter Gimsing; Orhan Sezer; Joseph Mikhael; Jin Lu; Meletios Dimopoulos; Amitabha Mazumder; Antonio Palumbo; Rafat Abonour; Kenneth Anderson; Michel Attal; Joan Blade; Jenny Bird; Michele Cavo; Raymond Comenzo; Javier de la Rubia; Hermann Einsele; Ramon Garcia-Sanz; Jens Hillengass; Sarah Holstein; Hans Erik Johnsen; Douglas Joshua; Guenther Koehne; Shaji Kumar; Robert Kyle; Xavier Leleu; Sagar Lonial; Heinz Ludwig; Hareth Nahi; Anil Nooka; Robert Orlowski; Vincent Rajkumar; Anthony Reiman; Paul Richardson; Eloisa Riva; Jesus San Miguel; Ingemar Turreson; Saad Usmani; David Vesole; William Bensinger; Muzaffer Qazilbash; Yvonne Efebera; Mohamed Mohty; Christina Gasparreto; James Gajewski; Charles F LeMaistre; Chris Bredeson; Phillipe Moreau; Marcelo Pasquini; Nicolaus Kroeger; Edward Stadtmauer
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-30       Impact factor: 5.742

9.  Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country.

Authors:  N Ben Abdejlil; D Belloumi; M Mâammar; R El Fatimi; L Torjman; A Lakhal; F Jenhani; S Hmida; T Ben Othman; S Ladeb
Journal:  Bone Marrow Transplant       Date:  2016-10-24       Impact factor: 5.483

10.  Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma.

Authors:  R L Olin; D T Vogl; D L Porter; S M Luger; S J Schuster; D E Tsai; D L Siegel; R J Cook; P A Mangan; K Cunningham; E A Stadtmauer
Journal:  Bone Marrow Transplant       Date:  2008-10-13       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.